All I want to know is was QRX aware of the FDA's position, prior to the Adcom meeting and that is the drug is not effective enough and will be rejected.
I find it hard to beleive QRX would not know the FDA's position.
How can this not be made clear by the FDA well before those briefing notes from the FDA, just before the Adcom meeting, where we all learned the decision had already been made and the meeting was a complete waste of time.
We have been shafted by QRX or the FDA.
- Forums
- ASX - By Stock
- conference call
All I want to know is was QRX aware of the FDA's position, prior...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)